- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 23 residues within 4Å:- Chain A: V.25, G.26, G.28, A.29, V.30, D.51, V.52, I.53, T.94, A.95, G.96, I.115, I.119, V.135, S.136, N.137, V.139, S.160, L.164, H.192, T.247, I.251
- Ligands: D0V.4
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:L.164, A:I.251, A:I.251
- Hydrogen bonds: A:V.27, A:V.30, A:V.52, A:G.96, A:V.135, A:N.137, A:N.137, A:S.160
- Water bridges: A:G.28, A:G.31, A:Y.82
NAD.6: 26 residues within 4Å:- Chain B: V.25, G.26, V.27, G.28, A.29, V.30, D.51, V.52, I.53, K.56, T.94, A.95, G.96, R.98, I.115, I.119, V.135, S.136, N.137, V.139, S.160, L.164, H.192, T.247, I.251
- Ligands: D0V.8
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:L.164, B:I.251, B:I.251
- Hydrogen bonds: B:V.27, B:A.29, B:V.30, B:V.52, B:K.56, B:K.56, B:V.135, B:N.137, B:N.137, B:S.160
- Water bridges: B:G.28, B:G.31
- Salt bridges: B:R.98
NAD.10: 23 residues within 4Å:- Chain C: V.25, G.26, G.28, A.29, V.30, D.51, V.52, I.53, T.94, A.95, G.96, I.115, I.119, V.135, S.136, N.137, V.139, S.160, L.164, H.192, T.247, I.251
- Ligands: D0V.12
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:L.164, C:I.251, C:I.251
- Hydrogen bonds: C:V.27, C:A.29, C:V.30, C:V.52, C:V.135, C:N.137, C:N.137, C:S.160
- Water bridges: C:G.28, C:G.31
NAD.13: 24 residues within 4Å:- Chain D: V.25, G.26, V.27, G.28, A.29, V.30, D.51, V.52, I.53, T.94, A.95, G.96, I.115, I.119, V.135, S.136, N.137, V.139, S.160, L.164, H.192, T.247, I.251
- Ligands: D0V.15
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:L.164, D:I.251, D:I.251
- Hydrogen bonds: D:V.27, D:A.29, D:V.30, D:V.52, D:G.96, D:V.135, D:N.137, D:N.137, D:S.160
- Water bridges: D:G.28, D:G.31
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: R.170, H.185
- Chain C: L.182, H.185
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain C- Water bridges: A:W.187, C:H.185
- Salt bridges: A:R.170, A:H.185, C:H.185
SO4.7: 4 residues within 4Å:- Chain B: R.170, H.185, W.187
- Chain D: H.185
8 PLIP interactions:5 interactions with chain D, 3 interactions with chain B- Water bridges: D:S.183, D:H.185, D:H.185, D:A.206, B:R.170
- Salt bridges: D:H.185, B:R.170, B:H.185
SO4.11: 4 residues within 4Å:- Chain A: L.182, H.185
- Chain C: R.170, H.185
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain A- Water bridges: C:R.170, C:W.187, A:A.206
- Salt bridges: C:R.170, C:H.185, A:H.185
- Hydrogen bonds: A:L.182
SO4.14: 3 residues within 4Å:- Chain B: H.185
- Chain D: R.170, H.185
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain D- Water bridges: B:A.206, D:V.269
- Salt bridges: B:H.185, D:R.170, D:H.185
- 4 x D0V: (2R)-5-[(2-chlorophenyl)sulfanyl]-6'-[(4-fluorophenyl)amino]-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
D0V.4: 15 residues within 4Å:- Chain A: L.108, N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.2
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:N.137, A:V.234, A:A.237, A:I.241
- Hydrogen bonds: A:N.137, A:R.168, A:R.168, A:H.192, A:T.247
- pi-Stacking: A:Y.238
D0V.8: 15 residues within 4Å:- Chain B: L.108, N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.6
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:N.137, B:V.234, B:A.237, B:I.241, B:I.241
- Hydrogen bonds: B:N.137, B:R.168, B:R.168, B:H.192, B:T.247
- pi-Stacking: B:Y.238
D0V.12: 15 residues within 4Å:- Chain C: N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.10
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:N.137, C:V.234, C:A.237, C:I.241, C:I.241
- Hydrogen bonds: C:N.137, C:R.168, C:R.168, C:H.192
- pi-Stacking: C:Y.238
D0V.15: 16 residues within 4Å:- Chain D: Q.99, L.108, N.137, P.138, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.13
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:N.137, D:V.234, D:A.237, D:I.241, D:I.241
- Hydrogen bonds: D:N.137, D:R.168, D:R.168, D:H.192, D:T.247
- Water bridges: D:Y.238
- pi-Stacking: D:Y.238
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-17
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x D0V: (2R)-5-[(2-chlorophenyl)sulfanyl]-6'-[(4-fluorophenyl)amino]-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-17
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D